bioAffinity Technologies, Inc. (BIAF)
2.03
-0.09
(-4.25%)
USD |
NASDAQ |
May 08, 16:00
2.02
-0.01
(-0.49%)
After-Hours: 20:00
bioAffinity Technologies EPS Diluted (Quarterly) : -0.8077 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veracyte, Inc. | 0.353 |
| Insight Molecular Diagnostics, Inc. | -0.7159 |
| Exagen, Inc. | -0.1982 |
| GRAIL, Inc. | -2.293 |
| FONAR Corp. | 0.3058 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.631M |
| Revenue (Quarterly) | 1.352M |
| Total Expenses (Quarterly) | 4.982M |
| Enterprise Value | 7.417M |
| Gross Profit Margin (Quarterly) | 22.82% |
| Profit Margin (Quarterly) | -268.6% |
| Earnings Yield | -557.3% |
| Normalized Earnings Yield | -422.69 |